BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36251366)

  • 21. Therapeutic benefit of second-look transurethral resection of bladder tumors for newly diagnosed T1 bladder cancer: a single-center experience.
    Tseng WH; Liu CL; Huang SK; Liao AC; Kuo JR; Hun SH; Chen CH; Su CC; Wang JC; Lee KH; Shen KH; Li CF
    Int Urol Nephrol; 2019 Aug; 51(8):1335-1342. PubMed ID: 31129781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of surgical checklist during transurethral resection increases detrusor muscle collection rate and improves recurrence-free survival in patients with non-muscle-invasive bladder cancer.
    Taoka R; Tsunemori H; Matsuoka Y; Kohashiguchi K; Miura T; Tohi Y; Miyauchi Y; Kato T; Ueda N; Sugimoto M
    Int J Urol; 2021 Jul; 28(7):727-732. PubMed ID: 33742465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer.
    Richterstetter M; Wullich B; Amann K; Haeberle L; Engehausen DG; Goebell PJ; Krause FS
    BJU Int; 2012 Jul; 110(2 Pt 2):E76-9. PubMed ID: 22313727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.
    Fujita N; Hatakeyama S; Momota M; Tobisawa Y; Yoneyama T; Yamamoto H; Imai A; Ito H; Yoneyama T; Hashimoto Y; Yoshikawa K; Ohyama C
    Urol Oncol; 2020 Oct; 38(10):795.e9-795.e17. PubMed ID: 32417111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transurethral resection of bladder tumor and the need for re-transurethral resection of bladder tumor: time to change our practice?
    Soria F; Giordano A; Gontero P
    Curr Opin Urol; 2020 May; 30(3):370-376. PubMed ID: 32205809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
    BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeat Transurethral Resection for Non-muscle-invasive Bladder Cancer: An Updated Systematic Review and Meta-analysis in the Contemporary Era.
    Yanagisawa T; Kawada T; von Deimling M; Bekku K; Laukhtina E; Rajwa P; Chlosta M; Pradere B; D'Andrea D; Moschini M; Karakiewicz PI; Teoh JY; Miki J; Kimura T; Shariat SF
    Eur Urol Focus; 2024 Jan; 10(1):41-56. PubMed ID: 37495458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The presence of detrusor muscle in the pathological specimen after transurethral resection of primary pT1 bladder tumors and its relationship to operator experience.
    Rouprêt M; Yates DR; Varinot J; Phé V; Chartier-Kastler E; Bitker MO; Compérat E
    Can J Urol; 2012 Oct; 19(5):6459-64. PubMed ID: 23040628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presence of detrusor muscle in bladder tumor specimens--predictors and effect on outcome as a measure of resection quality.
    Shoshany O; Mano R; Margel D; Baniel J; Yossepowitch O
    Urol Oncol; 2014 Jan; 32(1):40.e17-22. PubMed ID: 23911682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Standard Transurethral Resection
    O'Sullivan NJ; MacCraith E; Temperley HC; Naughton A; Davis NF
    J Endourol; 2023 Mar; 37(3):304-315. PubMed ID: 36367162
    [No Abstract]   [Full Text] [Related]  

  • 31. How well do we manage non-muscle invasive bladder tumors? A UK audit of real-life practices.
    Sountoulides P; Mutomba WF; Bouras E; Lim J; Bourdoumis A; Jain A
    Urologia; 2020 Aug; 87(3):142-148. PubMed ID: 31959070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced Visualization Methods for First Transurethral Resection of Bladder Tumour in Suspected Non-muscle-invasive Bladder Cancer: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(12):1-123. PubMed ID: 34484486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year Results.
    Naito S; Algaba F; Babjuk M; Bryan RT; Sun YH; Valiquette L; de la Rosette J;
    Eur Urol; 2016 Sep; 70(3):506-15. PubMed ID: 27117749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The value of surgeon's perception during transurethral resection of bladder tumors: can we trust in our eyes and experience to predict grade and staging?
    Vale L; Sousa J; Abreu-Mendes P; Vale P; Dias N; Dinis P; Antunes-Lopes T; Silva J
    Porto Biomed J; 2022; 7(4):e179. PubMed ID: 36186116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder Tumours.
    Mostafid H; Kamat AM; Daneshmand S; Palou J; Taylor JA; McKiernan J; Catto J; Babjuk M; Soloway M
    Eur Urol Oncol; 2021 Feb; 4(1):12-19. PubMed ID: 32684515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravesical BCG therapy with photodynamic diagnosis-guided transurethral resection of bladder tumors improves recurrence-free survival.
    Nakagawa R; Nohara T; Naito R; Kadomoto S; Iwamoto H; Yaegashi H; Kawaguchi S; Shigehara K; Izumi K; Kadono Y; Mizokami A
    Photodiagnosis Photodyn Ther; 2023 Jun; 42():103574. PubMed ID: 37080348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transurethral resection of bladder tumour (TURBT) as a day-case: A real-world practice and patients' perspective from a district general hospital (DGH).
    Ippoliti S; Bhatt NR; Ilie CP
    Urologia; 2023 Feb; 90(1):68-74. PubMed ID: 35819224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An International Collaborative Consensus Statement on En Bloc Resection of Bladder Tumour Incorporating Two Systematic Reviews, a Two-round Delphi Survey, and a Consensus Meeting.
    Teoh JY; MacLennan S; Chan VW; Miki J; Lee HY; Chiong E; Lee LS; Wei Y; Yuan Y; Yu CP; Chow WK; Poon DM; Chan R; Lai F; Ng CF; Breda A; Kramer MW; Malavaud B; Mostafid H; Herrmann T; Babjuk M
    Eur Urol; 2020 Oct; 78(4):546-569. PubMed ID: 32389447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Detrusor Muscle Sampling Rate in Monopolar and Bipolar Transurethral Resection of Bladder Tumor: A Randomized Trial.
    Teoh JY; Chan ES; Yip SY; Tam HM; Chiu PK; Yee CH; Wong HM; Chan CK; Hou SS; Ng CF
    Ann Surg Oncol; 2017 May; 24(5):1428-1434. PubMed ID: 27882470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of Risk Factors for Recurrence after Transurethral Resection of Bladder Tumor in Patients with Non-Muscle Invasive Bladder Cancer: 2-Year Follow-Up Outcomes.
    Li H; Wang L; Li H; Zhang P; Li Z; Xue L; Wang Z; Fu D; Chen Q; Luo Q; Chong T; Wang Z
    Oncology; 2024; 102(4):337-342. PubMed ID: 37647883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.